Cure Addiction Now Forum and Webinar
Thank you to everyone who joined us for the Patient Panel Discussion on November 10, 2025. Your engagement and thoughtful participation made the event truly impactful. You can watch the full recording below to revisit the insights and conversations shared.
Panelists
Colby Betschart, Recovery Advocate
Lisa Breckenridge, Panel Moderator
R. Andrew Chambers, MD, Indiana University
Kathryn A. Cunningham, PhD, FASPET, UTMB
Nancy Davis, CAN Founder and President
Adam Kaplin, MD, PhD, President Mira1a Pharma, Adjunct Faculty Johns Hopkins
Kelly E. Dunn, PhD, MBA, University of Maryland
Paul J. Kenny, PhD, Mount Sinai
Courtney Miller, PhD, UF Scripps Biomedical Research
Kurt Rasmussen, PhD, Chair, Scientific Advisory Board
Isabella Rickel, Advocate and Co-Chair of CAN
Lisa Vidal, Actress and Advocate
Sharon Walsh, PhD, University of Kentucky
Agenda
I. Welcome: Nancy Davis, Founder and President of CAN and Isabella Rickel, CAN Board Member
II. Moderator and Introduction of Panel: Kurt Rasmussen, Ph.D., CSO Delix Therapeutics
- Topic 1: Living with Substance Use Disorder: Madison Mastera, Guest Speaker
- Topic 2: Current State of SUD/OUD Treatment: Where Are the Gaps? Kelly E. Dunn, Ph.D., Johns Hopkins University School of Medicine and Justin C. Strickland, Ph.D., Johns Hopkins University School of Medicine
- Topic 3: Living with Substance Use Disorder: Jason Wahler, CAN Board Member
- Topic 4: Overdose Protection
- OTC Naloxone: Judy Ashworth, M.D., SVP at Pinney Associates and CMO of Harm Reduction Therapeutics
- New Dangers of Fentanyl Pills and Adolescent Overdose / Tranq (Xylazine) used as an adulterant: Chris Evans Ph.D., UCLA
- Topic 5: Living with Substance Use Disorder: Brennan Ward, Guest Speaker (Via Zoom)
- Topic 6: New Therapies in the Pipeline
- Ibogaine as a Therapy: Deborah C. Mash, Ph.D., University of Miami School of Medicine (Via Zoom)
- Developing Biobehavioral Phenotyping Strategies to personalize SUD treatment: Kathryn A. Cunningham, Ph.D. University of Texas Medical Branch
- Ketamine as a Therapy: John H. Krystal, M.D., Yale University (Via Zoom)
- Development of a Single-use Medication: Courtney A. Miller, Ph.D., Scripps Research (Via Zoom)
- Screening for New Medications: Garret Stuber, Ph.D., University of Washington (Via Zoom)
- Bitter Bodyguards: How Chemosensing Can Uncover New Therapeutics: Stephanie P.B. Caligiuri, Ph.D., Icahn School of Medicine at Mount Sinai
- Topic 7: Mental Health and Substance Use Disorder: Adam Kaplin, M.D, Ph.D., CSO MyMD Pharmaceuticals
IV. Lightning Round: Answers to Submitted Questions
V. Conclusion and Thank You by Nancy Davis
2025 Gallery

alt="Nov 2025 Cure Addiction Now Forum Demonstration" width="500" height="300" />
alt="Nov 2025 Cure Addiction Now Forum Presenter" width="500" height="300" />

To view the full gallery, click here.
